PL378587A1 - Sposób wytwarzania (S)-(-)-2-amino-6-n-propyloamino-4,5,6,7-tetrahydrobenzotiazolu i/lub jego soli - Google Patents

Sposób wytwarzania (S)-(-)-2-amino-6-n-propyloamino-4,5,6,7-tetrahydrobenzotiazolu i/lub jego soli

Info

Publication number
PL378587A1
PL378587A1 PL378587A PL37858705A PL378587A1 PL 378587 A1 PL378587 A1 PL 378587A1 PL 378587 A PL378587 A PL 378587A PL 37858705 A PL37858705 A PL 37858705A PL 378587 A1 PL378587 A1 PL 378587A1
Authority
PL
Poland
Prior art keywords
tetrahydrobenzotiazole
propyloamino
salts
amino
methods
Prior art date
Application number
PL378587A
Other languages
English (en)
Inventor
Roman Balicki
Michał Odrowąż-Sypniewski
Agnieszka Ciesielska
Wiesław Szelejewski
Joanna Zagrodzka
Grażyna Cieplucha
Original Assignee
Instytut Farmaceutyczny
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Instytut Farmaceutyczny filed Critical Instytut Farmaceutyczny
Priority to PL378587A priority Critical patent/PL378587A1/pl
Priority to PCT/PL2006/000093 priority patent/WO2007075095A1/en
Priority to EP06835775A priority patent/EP2051971A1/en
Publication of PL378587A1 publication Critical patent/PL378587A1/pl
Priority to US12/164,005 priority patent/US20090105483A1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/60—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings condensed with carbocyclic rings or ring systems
    • C07D277/62—Benzothiazoles
    • C07D277/68—Benzothiazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2
    • C07D277/82—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Psychology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL378587A 2005-12-29 2005-12-29 Sposób wytwarzania (S)-(-)-2-amino-6-n-propyloamino-4,5,6,7-tetrahydrobenzotiazolu i/lub jego soli PL378587A1 (pl)

Priority Applications (4)

Application Number Priority Date Filing Date Title
PL378587A PL378587A1 (pl) 2005-12-29 2005-12-29 Sposób wytwarzania (S)-(-)-2-amino-6-n-propyloamino-4,5,6,7-tetrahydrobenzotiazolu i/lub jego soli
PCT/PL2006/000093 WO2007075095A1 (en) 2005-12-29 2006-12-29 Process for the preparation of pramipexole base and/or its salts
EP06835775A EP2051971A1 (en) 2005-12-29 2006-12-29 Process for the preparation of pramipexole base and/or its salts
US12/164,005 US20090105483A1 (en) 2005-12-29 2008-06-28 Process for the preparation of pramipexole base and/or its salts

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
PL378587A PL378587A1 (pl) 2005-12-29 2005-12-29 Sposób wytwarzania (S)-(-)-2-amino-6-n-propyloamino-4,5,6,7-tetrahydrobenzotiazolu i/lub jego soli

Publications (1)

Publication Number Publication Date
PL378587A1 true PL378587A1 (pl) 2007-07-09

Family

ID=37946221

Family Applications (1)

Application Number Title Priority Date Filing Date
PL378587A PL378587A1 (pl) 2005-12-29 2005-12-29 Sposób wytwarzania (S)-(-)-2-amino-6-n-propyloamino-4,5,6,7-tetrahydrobenzotiazolu i/lub jego soli

Country Status (4)

Country Link
US (1) US20090105483A1 (pl)
EP (1) EP2051971A1 (pl)
PL (1) PL378587A1 (pl)
WO (1) WO2007075095A1 (pl)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8518926B2 (en) 2006-04-10 2013-08-27 Knopp Neurosciences, Inc. Compositions and methods of using (R)-pramipexole
CN102160865A (zh) 2006-05-16 2011-08-24 诺普神经科学股份有限公司 R(+)和s(-)普拉克索的组合物以及使用该组合物的方法
US8524695B2 (en) 2006-12-14 2013-09-03 Knopp Neurosciences, Inc. Modified release formulations of (6R)-4,5,6,7-tetrahydro-N6-propyl-2,6-benzothiazole-diamine and methods of using the same
JP2010521496A (ja) 2007-03-14 2010-06-24 ノップ ニューロサイエンシーズ、インク． キラル精製置換ベンゾチアゾールジアミンの合成
EP2334185A4 (en) * 2008-08-19 2011-09-21 Knopp Neurosciences Inc COMPOSITIONS AND METHODS FOR USE OF (R) -PRAMIPEXOL
US9512096B2 (en) 2011-12-22 2016-12-06 Knopp Biosciences, LLP Synthesis of amine substituted 4,5,6,7-tetrahydrobenzothiazole compounds
US9662313B2 (en) 2013-02-28 2017-05-30 Knopp Biosciences Llc Compositions and methods for treating amyotrophic lateral sclerosis in responders
CN104072442B (zh) * 2013-03-28 2016-09-28 成都弘达药业有限公司 一种化合物及其制备方法
US9468630B2 (en) 2013-07-12 2016-10-18 Knopp Biosciences Llc Compositions and methods for treating conditions related to increased eosinophils
SMT202100119T1 (it) 2013-07-12 2021-05-07 Knopp Biosciences Llc Trattamento dei livelli elevati di eosinofili e/o basofili
EP3033081B1 (en) 2013-08-13 2021-05-12 Knopp Biosciences LLC Compositions and methods for treating chronic urticaria
ES2813674T3 (es) 2013-08-13 2021-03-24 Knopp Biosciences Llc Composiciones y métodos para el tratamiento de trastornos de células plasmáticas y trastornos prolinfocíticos de células b
CN107540633A (zh) * 2016-06-24 2018-01-05 江苏神龙药业有限公司 一种普拉克索及其盐酸盐的工业化制备方法
CN107540632A (zh) * 2016-06-27 2018-01-05 江苏神龙药业股份有限公司 一种普拉克索单盐酸盐的新晶型及其制备方法
CN111072593B (zh) * 2019-12-31 2022-11-08 江苏天和制药有限公司 一种盐酸普拉克索的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3572485D1 (en) * 1984-12-22 1989-09-28 Thomae Gmbh Dr K Tetrahydro-benzothiazoles, their production and their use as intermediates or drugs
ES2187249B1 (es) * 2000-09-18 2004-09-16 Synthon Bv Procedimiento para la preparacion de 2-amino-6-(alquil)amino-4,5,6,7-tetrahidrobenzotiazoles.
US7365086B2 (en) * 2003-07-25 2008-04-29 Synthon Ip Inc. Pramipexole acid addition salts
DE602005025988D1 (de) * 2004-03-19 2011-03-03 Dipharma Francis Srl Zwischenprodukte für die herstellung von pramipexol

Also Published As

Publication number Publication date
EP2051971A1 (en) 2009-04-29
WO2007075095A1 (en) 2007-07-05
US20090105483A1 (en) 2009-04-23

Similar Documents

Publication Publication Date Title
HUS1800010I1 (hu) 4-Fenil-6-(2,2,2-trifluor-1-feniletoxi)pirimidin-alapú vegyületek és alkalmazási eljárásaik
IL184901A0 (en) 2,4-diamino-pyridopyrimidine derivatives and their use as mtor inhibitors
ZA200709043B (en) Benzodioxane and benzodioxalane derivatives and uses thereof
AP2358A (en) Thiazole compounds and methods of use.
PL1859004T3 (pl) Środki sieciujące kompozycję opracowania odwiertu oraz ich zastosowania
IL185280A0 (en) Tetrahydroindolone and tetrahydroindazolone derivatives
PL2057153T3 (pl) POCHODNE (3-ARYLO-PIPERAZYN-1-YLOWE) 6,7-DIALKOKSYCHINAZOLINY, 6,7-DIALKOKSYFTALAZYNY i 6,7-DIALKOKSYIZOCHINOLINY
IL184722A0 (en) Novel haloalkylsulfonanilide derivative, herbicide, and method of use thereof
EP1951680A4 (en) NOVEL 2-AMINOPYRIMIDINONE DERIVATIVES AND THEIR USE
IL187620A0 (en) 17??-hsd1 and sts inhibitors
EP1897882A4 (en) SUBSTITUTED PURINE DERIVATIVES OF AN N2-QUINOLEYL OR ISOQUINOLYL GROUP, PREPARATIONS AND USES THEREOF
ZA200706672B (en) 2,4-Diamino-pyridopyrimidine derivatives and their use as mTOR inhibitors
IL189252A0 (en) Dihydroxyanthraquinones and their use
PL378587A1 (pl) Sposób wytwarzania (S)-(-)-2-amino-6-n-propyloamino-4,5,6,7-tetrahydrobenzotiazolu i/lub jego soli
EP1951682A4 (en) NEW 2-AMINOPYRIMIDONE OR 2-AMINOPYRIDINONE DERIVATIVES AND THEIR USE
AU2006321904A8 (en) 1, 1, 3-trioxo-1 , 2 , 5-thiadiazolidines and their use as PTP-ases inhibitors
GB0414594D0 (en) Aqueous composition 1
EP1874722A4 (en) HYDROXAMIC ACID DERIVATIVES AND PROCESSES FOR PREPARING THE SAME
ZA200804905B (en) Orthopaedic fastener
PL1683840T3 (pl) Odporne na redukcję pigmenty oparte na ferrycie cynkowym, sposób ich wytwarzania i ich zastosowanie
PL1786759T3 (pl) Nowe pochodne 3,5-seko-4-norcholestanowe i ich zastosowanie
IL190045A0 (en) Use of c3-c10 17 alfa-esters of 9,11-dehydrocortexolone as anti-gonadotrophic agents
EP1954817A4 (en) KIFS AS RHO WAY MODIFICATORS AND METHOD OF USE
GB0514629D0 (en) 2,6,8-trisubstituted 1-deazapurines and their different uses
SI2013191T1 (sl) 3,7-diamino-10H-fenotiazinske soli in njihova uporaba

Legal Events

Date Code Title Description
REFS Decisions on refusal to grant patents (taken after the publication of the particulars of the applications)